CASE REPORT

A 52-year-old woman’s medical check-up and ultrasonography revealed a 6.2-cm-sized mass in the right breast, which was diagnosed as invasive lobular carcinoma by needle biopsy. Before surgery, the patient underwent a full-body evaluation. Computed tomography revealed a mass in the right lung, which was diagnosed as pulmonary adenocarcinoma by needle biopsy (Fig. 1). Since the patient was suspected to have synchronous primary carcinomas in her lung and right breast with no sign of metastasis, she underwent right lower lobectomy for the lung adenocarcinoma and right mastectomy for the invasive lobular carcinoma of the right breast. The lung mass measured 2.3 cm in diameter. Microscopically, most of the lung mass exhibited typical growth patterns of lung adenocarcinoma. However, in one focus, the tumor cells showed a different arrangement and cytology; the tumor cells had minimal cytoplasm without nucleoli in a compact trabecular pattern. The typical adenocarcinoma cells were positive for thyroid transcription factor-1 (TTF-1) and E-cadherin and negative for estrogen and progesterone receptors. In contrast, tumor cells in the morphologically different focus expressed immunoreactivity for estrogen and progesterone receptors while they were negative for TTF-1 and E-cadherin (Fig. 2). Based on these findings, we concluded that the invasive lobular carcinoma of the patient’s right breast had metastasized to the lung adenocarcinoma. This study was approved by the Institutional Review Board of Jeonbuk National University Hospital with a waiver of informed consent (IRB No. 2019-05-027).

DISCUSSION

TTM is an extremely rare phenomenon. Moreover, only approximately 180 cases have been reported in English literature. The most referenced and used criteria to diagnose TTM were proposed by Campbell et al. [3] as follows: (1) more than one primary tumor must be present; (2) the recipient tumor must be a true benign or malignant neoplasm; (3) the metastatic neoplasm must be a true metastasis with established growth in the host’s tumor, not the result of contiguous growth (‘collision tumor’) or embolization of tumor cells; and (4) tumors that have metastasized to the lymph nodes with existing lymphoreticular malignant tumors are excluded.

According to previous reports, renal cell carcinoma and meningioma are common recipient tumors of TTM (Table 1) [1]. They are both rich in vasculature and have high cytoplasmic lipid and glycogen content [4]. These conditions might be able to serve as a favorable microenvironment for disseminated cancer cells to metastasize. The lung is one of the most frequent sites of metastasis for extrathoracic malignancies. However, lung carcinomas are extremely rare to serve as a recipient tumor in a TTM phenomenon [1,2,5-7]. A possible explanation for this paradox is that lung carcinomas, when compared with normal lungs, are often accompanied by fibrosis and are lacking in the rich network of thin-walled vasculature [6,8]. Additionally, most lung carcinomas grow rapidly; therefore, they are less likely to provide enough nutrition for the immigrant cancer cells than renal cell carcinoma or meningioma [8].

A lung mass detected in a patient with a history of prior cancer proves to be a big challenge to clinicians, radiologists, and pathologists. Even worse, in TTM cases like our patient, it is nearly impossible for a radiologist to detect the metastatic lesion located inside the primary tumor. Besides, the needle biopsy, if not containing both primary and metastatic tumors of the mass, could be of no use. In our study, we interpreted the needle biopsy of the lung mass as a primary lung adenocarcinoma. Even after evaluation of the resection specimen, it is not an easy task to detect the metastasis whose focus is small and embedded in the recipient tumor. Therefore, if pathologists identify a histologically different focus in a morphologically typical primary lung tumor of a patient with two different primary cancers, they should always take TTM occurrence into consideration despite the slim chance.

In conclusion, we report a rare case of an invasive lobular carcinoma of the breast metastasizing to a lung adenocarcinoma. To avoid an incorrect diagnosis of a tumor with dimorphic appearance, the TTM phenomenon should be considered as a possibility. Moreover, it is of great importance to identify metastases because metastatic and non-metastatic tumors require different treatments.

Fig. 1.

High resolution view of computed tomography scan shows pulmonary mass (arrow). The mass is located at right lower lobe of the lung and shows ground glass opacity.

Fig. 2.

Histologic features of the breast needle biopsy and resected lung mass. (A) The tumor cells of the breast mass are arranged in infiltrating single linear cords. (B) Scan view of the pulmonary mass shows dimorphic growth pattern (circular area vs. other region). (C) Higher magnification of the circular area of Fig. 2B. The tumor cells are arranged in compact trabecular pattern with minimal cytoplasm. (D) Other region of the lung mass showing typical acinar growth pattern. The tumor cells of the circular area of panel B are negative for thyroid transcription factor-1 (E) and E-cadherin (F) and positive for estrogen (G) and progesterone receptor (H).

REFERENCES

• 1. Petraki C, Vaslamatzis M, Argyrakos T, et al. Tumor to tumor metastasis: report of two cases and review of the literature. Int J Surg Pathol 2003; 11: 127-35. ArticlePubMed
• 2. Piacentini F, Rossi G, Casali C, Cadioli A, Barbieri E, Guarneri V. Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications. Lung Cancer 2011; 74: 145-8. ArticlePubMed
• 3. Campbell LV Jr, Gilbert E, Chamberlain CR Jr, Watne AL. Metastases of cancer to cancer. Cancer 1968; 22: 635-43. ArticlePubMed
• 4. Ortega P Jr, Li IY, Shimkin M. Metastasis of neoplasms to other neoplasms. Ann West Med Surg 1951; 5: 601-9. ArticlePubMed
• 5. Kim KM, Kim YN, Chu HH, Jin HY, Kim MH, Chung MJ. Papillary carcinoma of thyroid metastatic to adenocarcinoma in situ of lung: report of an unusual case. Korean J Pathol 2012; 46: 282-6. ArticlePubMedPMCPDF
• 6. Lee T, Cha YJ, Ahn S, Han J, Shim YM. A rare case of tumor-to-tumor metastasis of thyroid papillary carcinoma within a pulmonary adenocarcinoma. J Pathol Transl Med 2015; 49: 78-80. ArticlePubMedPMCPDF
• 7. Roscoe KJ, Raja S, Tronic B, Dou Y. Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer. Clin Nucl Med 2006; 31: 359-60. ArticlePubMed
• 8. Xue L, Luan Z, Liu Y, et al. Pulmonary metastasis of a papillary thyroid carcinoma and primary lung adenocarcinoma: two coincident carcinomas at the same location. Diagn Pathol 2013; 8: 26.ArticlePubMedPMCPDF

Figure & Data

References

Citations

Citations to this article as recorded by  

• Tumor-in-Tumor-Metastase: Ein seltenes Phänomen
  Felix Elsner, Katharina Keller, Florian Fuchs, Michael Uder, Arndt Hartmann
  Die Pathologie.2024;[Epub]     CrossRef
• Tumor-to-Tumor Metastases Involving Clear Cell Renal Cell Carcinomas: A Diagnostic Challenge for Pathologists Needing Clinical Correlation
  Claudia Manini, Claudia Provenza, Leire Andrés, Igone Imaz, Rosa Guarch, Raffaelle Nunziata, José I. López
  Clinics and Practice.2023; 13(1): 288.     CrossRef
• Metástasis tumor a tumor en pulmón: reporte de tres casos y revisión de la literatura
  Paula Cristina Castro Quiroga, Blanca Viviana Fajardo Idrobo, Diana Marcela Caicedo Ruiz, Julieth Alexandra Franco Mira, Carlos Andrés Carvajal Fierro, Alfredo Ernesto Romero Rojas, Rafael Santiago Parra Medina
  Revista Colombiana de Cancerología.2023; 27(1): 107.     CrossRef
• Lobular to Lobule: Metastatic Breast Carcinoma to Olfactory Neuroblastoma
  Kent M. Swimley, Silvana Di Palma, Lester D. R. Thompson
  Head and Neck Pathology.2021; 15(2): 642.     CrossRef
• A case of colorectal cancer with intratumoral metastasis to primary lung cancer
  Yasushi Cho, Mitsuhito Kaji, Shunsuke Nomura, Yusuke Motohashi, Masaaki Sato, Motoya Takeuchi
  The Journal of the Japanese Association for Chest Surgery.2021; 35(5): 576.     CrossRef